Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Michelle Kahlenberg

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Seminars in Arthritis and Rheumatism|July 27, 2010
Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndromeJ Michelle Kahlenberg
The Journal of Investigative Dermatology|July 2, 2020
Rethinking the Pathogenesis of Cutaneous LupusJ Michelle Kahlenberg
Current Opinion in Rheumatology|February 10, 2016
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockadeJ Michelle Kahlenberg
Nature Immunology|July 28, 2021
Mentorship of physician scientists: a critical imperativeJ Michelle Kahlenberg
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2019
Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune DiseasesJ Michelle Kahlenberg, Insoo Kang
Annual Review of Medicine|July 8, 2022
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic ApproachesStephanie Lazar, J Michelle Kahlenberg
Current Opinion in Rheumatology|February 1, 2024
Emerging biologic therapies for systemic lupus erythematosusHiroshi Kato, J Michelle Kahlenberg
Arthritis Research & Therapy|March 5, 2011
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosusJ Michelle Kahlenberg, Mariana J Kaplan
Journal of Leukocyte Biology|July 9, 2004
Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and releaseJ Michelle Kahlenberg, George R Dubyak
Current Opinion in Rheumatology|July 4, 2014
The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?J Michelle Kahlenberg, Mariana J Kaplan
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Seminars in Arthritis and Rheumatism|July 27, 2010
Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndromeJ Michelle Kahlenberg
The Journal of Investigative Dermatology|July 2, 2020
Rethinking the Pathogenesis of Cutaneous LupusJ Michelle Kahlenberg
Current Opinion in Rheumatology|February 10, 2016
Anti-inflammatory panacea? The expanding therapeutics of interleukin-1 blockadeJ Michelle Kahlenberg
Nature Immunology|July 28, 2021
Mentorship of physician scientists: a critical imperativeJ Michelle Kahlenberg
Arthritis & Rheumatology (Hoboken, N.J.)|September 29, 2019
Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune DiseasesJ Michelle Kahlenberg, Insoo Kang
Annual Review of Medicine|July 8, 2022
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic ApproachesStephanie Lazar, J Michelle Kahlenberg
Current Opinion in Rheumatology|February 1, 2024
Emerging biologic therapies for systemic lupus erythematosusHiroshi Kato, J Michelle Kahlenberg
Arthritis Research & Therapy|March 5, 2011
The interplay of inflammation and cardiovascular disease in systemic lupus erythematosusJ Michelle Kahlenberg, Mariana J Kaplan
Journal of Leukocyte Biology|July 9, 2004
Differing caspase-1 activation states in monocyte versus macrophage models of IL-1beta processing and releaseJ Michelle Kahlenberg, George R Dubyak
Current Opinion in Rheumatology|July 4, 2014
The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?J Michelle Kahlenberg, Mariana J Kaplan
Pageof 18